Proteomic associations with forced expiratory volume: a Mendelian randomisation study.

"Declarations Ethics approval and consent to participateApproval for the AGES-Reykjavik study was obtained from the National Bioethics Committee in Iceland that acts as the Institutional Review Board for the Icelandic Heart Association (approval number: VSN-00-063), and by the National Institute on Aging Intramural Institutional Review Board. Consent for publicationNot applicable. Competing interestsJJL, YJW and LLJ are employees and stockholders of Novartis. GTA and GG report travel support from Boehringer-Ingelheim for work not related to the study. No other potential conflicts of interest relevant to this article were reported. Competing interests JJL, YJW and LLJ are employees and stockholders of Novartis. GTA and GG report travel support from Boehringer-Ingelheim for work not related to the study. No other potential conflicts of interest relevant to this article were reported."

"Funding The AGES-Reykjavik study was funded by Icelandic Heart Association, National Institute on Aging contract N01-AG-12100 and HHSN271201200022C, and Althingi (the Icelandic Parliament). GTA was supported by the Eimskip University Fund from the University of Iceland. GG was supported by the University of Iceland and by Landspitali University Hospital. TJ was supported by the Icelandic Research fund (Grant no. 206692-052) and VaG by the University of Iceland postdoctoral fund. All protein measurements were funded by Novartis Biomedical Research."